S0003733
Dolutegravir 50mg tabs/PAC-30
Dolutegravir 50mg tablets, in a bottle pack of 30 without or without outer carton.
Indicative Price 2.80 USD
General description:
Dolutegravir 50mg tablets, in a bottle pack of 30 without or without outer carton.
Technical specifications:
Each tablet contains dolutegravir sodium equivalent to 50 mg dolutegravir
Therapeutic class:
Dolutegravir is an integrase Inhibitor.
Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008:
http://apps.who.int/iris/bitstream/handle/10665/44053/9789241547659_eng. pdf?sequence=1
https://www.who.int/publications/i/item/9789241547659
For more details, please see WHO treatment guidelines https://www.who.int/publications/i/item/9789240031593 and WHO Essential Medicines Library https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02 or your regional/national guidelines.
Shelf life:
24 months
Storage conditions:
Do not store above 30°C
Component of a KIT:
This item is a component of S9901023 - IEHK2017, PEP kit (S1400653 - Dolutegravir 50mg tabs/PAC-30 gb)
Alternative products:
S1400653 - Dolutegravir 50mg tabs/PAC-30 gb
Related Products